Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis
December 06, 2022 at 13:19 PM EST
BTIGupgradedAerovate Therapeutics Inc(NASDAQ: AVTE) from Neutral to Buy with aprice target of $27. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.